Volume 93, Issue 2 , Pages 123-129, May 2006
Expression of CD28 and cytotoxic T lymphocyte antigen 4 at the maternal–fetal interface in women with unexplained pregnancy loss
Abstract
Objective
To investigate the expression of CD28 and CTLA-4, two costimulatory molecules involved in T-cell activation at the maternal–fetal interface in women with unexplained pregnancy loss.
Methods
A total of 57 women, 39 with unexplained spontaneous abortion (SA) and 18 with unexplained recurrent spontaneous abortion (RSA), were enrolled in the study. A high-resolution spectratyping analysis of fluorescent bands was performed to detect CD28 and CTLA-4 expression in decidual tissues.
Results
The mean expression of CTLA-4 mRNA was significantly higher in women with SA than in controls (P
<
0.05). Moreover, the expression of CTLA-4 was higher in SA patients with genotype AA and phenotype A+ (AA
+
AG) than in controls (P
<
0.01). The expression of CTLA-4 was not significantly different in patients with RSA and in controls. The expression of CD28 was significantly decreased in patients with RSA (P
<
0.01) and SA (P
<
0.05) compared with controls. The mean ratios of CTLA-4/CD28 were significantly higher in patients with RSA (P
<
0.01) and SA (P
<
0.05) than in controls.
Conclusions
This study suggests that an imbalance in CTLA-4/CD28 expression or suppressed T-cell activity at the maternal–fetal interface may confer susceptibility to unexplained pregnancy loss.
Keywords: Abortion, CD28, CTLA-4, Immunology
To access this article, please choose from the options below
PII: S0020-7292(06)00056-7
doi:10.1016/j.ijgo.2006.01.027
© 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Inc. All rights reserved.
Volume 93, Issue 2 , Pages 123-129, May 2006
